Skip to content

For investors

Salvus on one page.

Salvus is a healthtech founded in Recife, Brazil, in 2016. It develops connected devices, software and applied intelligence to improve continuity of care and health operations across hospitals, care transitions and homes.

Two product lines

What Salvus does.

  • ATAS O2, for hospitals

    Digital flowmeter that tracks hospital oxygen therapy at the point of use, with a dashboard for the teams.

    Learn about ATAS O2
  • HAI, for home care and health plans

    Home care management platform for home care companies and health plans: care plan, schedule, visits and indicators in the same flow.

    Learn about HAIHAI for health plans

Why now

The record of care still arrives late.

  • In the hospital

    The start, adjustment and end of oxygen therapy still depend on notes made afterwards and on systems that do not talk to each other. What was prescribed, consumed and recorded rarely match, and the gap can become loss or claim denials.

  • At home

    A home care operation coordinates patients, care plans (PADs), prescriptions, schedules, partners, visits, audits and billing. Spread across isolated systems, these processes make the team find out late what did not happen.

In operation · 2026

Salvus in operation.

  • +20 thousandpatients cared for
  • +7 thousandhealth professionals in the field with HAI
  • +790 thousandhome visits and shifts
  • +400 thousandoxygen therapy hours recorded

Traction

Growth from 2023 to 2026.

Oxygen therapy hours recorded by ATAS O2Sessions of up to 7 days. Average of about 50% a year from 2023 to 2026.
  1. 138 thousand2023
  2. 139 thousand2024
  3. 339 thousand2025
  4. about 503 thousand2026 (projection)
HAI visits and shiftsFrom 548 thousand in 2024 to about 794 thousand in 2026.
  1. 223 thousand2023
  2. 548 thousand2024
  3. 756 thousand2025
  4. about 794 thousand2026 (projection)

In 2023 the HAI base started mid-year, so the figure may be below the real one.

Salvus production data. 2026 projected from results through October.

Evidence

Science, awards and programs.

Discover Health Systems (Springer), v. 5, art. 70 · 2026Discrepancies in oxygen consumption between automated monitoring and electronic medical recordsMonnaka VU et al., Hospital Israelita Albert EinsteinPer bed, ATAS O2 recorded 566.9 hours of oxygen and the medical record, 163.6.DOI: 10.1007/s44250-026-00409-9 (opens in a new tab)

In all, there are 8 articles with a DOI and 2 undergraduate theses about Salvus and ATAS O2.

Awards and selections

  • 100 Startups to Watch · 2025PEGN and Época Negócios, with EloGroup
  • BNDES first IoT pilot · 2019BNDES Pilotos IoT
  • Top 1 Health at 100 Open Startups · 2018100 Open Startups
  • Empreenda Saúde Award · 2018Empreenda Saúde

Incubation and acceleration

  • Delta-V, Traction module · 2023Casa Azul Ventures, with Banco do Nordeste
  • Parqtel incubation (INBARCATEL) · 2019 and 2020Parqtel
  • Eretz.bio incubation · 2019Eretz.bio, Hospital Israelita Albert Einstein
  • Porto Digital incubation · 2017 to 2018Porto Digital
  • Start-Up Brasil, acceleration by Jump Brasil · 2017Start-Up Brasil and Jump Brasil (Porto Digital)

See press coverage, awards, programs and publications on the press page (in Portuguese)

Who already backs us

Investment and funding.

Investment

  • Eretz.bio
  • ACE Startups
  • MOR Capital
  • PPA Capital

Funding, acceleration and development partners

  • BNDES
  • FINEP
  • EMBRAPII
  • FACEPE
  • SOFTEX
  • Start-Up Brasil
  • Porto Digital
  • CESAR

Rounds and investors

Rounds and investors on Crunchbase and PitchBook

Information about funding rounds is kept on Salvus profiles in the directories, which they maintain.

Crunchbase (opens in a new tab)PitchBook (opens in a new tab)

Contact for investors.

Investor materials on request. Write to us with the subject Investors.